BioAdaptives' Zeranovia weight loss product shows 5-7 lbs/week loss in dosage trial

BIOADAPTIVES, INC.

Participants lost 5–7 pounds per week in Zeranovia dosage trial.
Minimal side effects: mild GI discomfort manageable by increasing water intake or adjusting dosage.
All trial subjects requested to proceed to next phase, indicating high satisfaction.
Company advancing to dosage adjustments for next-stage clinical trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.